ALPS Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952K | Sell |
166,075
-56,173
| -25% | -$322K | 0.01% | 512 |
|
|
2025
Q1 | $1.81M | Sell |
222,248
-19,367
| -8% | -$158K | 0.01% | 361 |
|
|
2024
Q4 | $2.28M | Buy |
241,615
+14,562
| +6% | +$137K | 0.01% | 327 |
|
|
2024
Q3 | $2.42M | Sell |
227,053
-3,984
| -2% | -$42.5K | 0.02% | 326 |
|
|
2024
Q2 | $2.29M | Buy |
+231,037
| New | +$2.29M | 0.02% | 318 |
|
|
2023
Q4 | – | Sell |
-211,895
| Closed | -$2.58M | – | 980 |
|
|
2023
Q3 | $2.58M | Buy |
211,895
+2,716
| +1% | +$33K | 0.02% | 287 |
|
|
2023
Q2 | $2.63M | Buy |
+209,179
| New | +$2.63M | 0.02% | 266 |
|
|
2022
Q4 | – | Sell |
-153,069
| Closed | -$1.6M | – | 1051 |
|
|
2022
Q3 | $1.6M | Sell |
153,069
-13,128
| -8% | -$137K | 0.02% | 353 |
|
|
2022
Q2 | $1.79M | Sell |
166,197
-121,599
| -42% | -$1.31M | 0.02% | 341 |
|
|
2022
Q1 | $2.73M | Sell |
287,796
-34,672
| -11% | -$328K | 0.03% | 173 |
|
|
2021
Q4 | $3.73M | Sell |
322,468
-4,242
| -1% | -$49K | 0.04% | 169 |
|
|
2021
Q3 | $3.12M | Sell |
326,710
-21,731
| -6% | -$208K | 0.03% | 215 |
|
|
2021
Q2 | $3.36M | Buy |
+348,441
| New | +$3.36M | 0.03% | 204 |
|